Diabetes, Metabolic, Endocrine
We focus on ensuring appropriate endpoints are met including glycemic control, insulin management, and enhanced hormonal management.
Clinical trials in diabetes, metabolic disorders, and endocrinology play a vital role in advancing our understanding of these conditions and improving patient care.
Common indications we have experience in include:
- Type 1 and Type 2 Diabetes Mellitus
- Obesity and Metabolic Syndrome
- Thyroid and Adrenal Disorders
- Hormone Replacement Therapy (HRT)
Pain points associated with clinical trials in diabetes, metabolic disorders and endocrinology
- Variable Disease Progression: Diabetes, metabolic, and endocrine disorders are heterogeneous in their progression. The variable disease patterns can affect the consistency of study results.
- Nutritional and Lifestyle Variabilities: Dietary habits, exercise routines, and other lifestyle factors play significant roles in these conditions, making it challenging to maintain consistency across participants.
- Long-Term Monitoring and Compliance: Given the chronic nature of these conditions, trials often require long-term monitoring, which can lead to attrition and inconsistencies in treatment adherence.
- Hormonal Fluctuations: Endocrine trials face challenges with hormonal fluctuations in participants, which can influence study outcomes.
- Complex Medication Interactions: Many patients with these disorders are on multiple medications. Interactions between study drugs and existing medications can pose safety concerns and skew results.
How iNGENū addresses these pain points
- Tailored Patient Segmentation: iNGENū employs stratified patient selection, ensuring participants have a similar disease progression stage, providing more consistent results.
- Dietary and Lifestyle Standardization: We collaborate with nutritionists and lifestyle experts to create standardized guidelines for participants during the trial. This reduces variability and ensures consistency in external influences.
- Long-Term Support and Engagement Platforms: We have developed a comprehensive patient support platform, specifically for diabetes and endocrine patients, that includes regular check-ins, reminders, and educational resources to boost long-term compliance.
- Hormone Monitoring Protocols: Our trials in the endocrine space include rigorous hormonal monitoring, using advanced hormonal assays to account for and manage hormonal fluctuations, ensuring that they don't interfere with trial outcomes.
- Detailed Medication Review: Before enrollment, we conduct a thorough review of a participant's medication regimen. This not only helps in selecting the right participants but also in predicting and monitoring potential drug interactions.